---
document_datetime: 2023-09-21 21:37:35
document_pages: 10
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/coagadex-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: coagadex-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 6.8362081
conversion_datetime: 2025-12-27 22:09:30.970108
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Coagadex

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                           | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|-------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| N/0049               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                | 17/01/2023                          |                                             | PL                               |           |
| IAIN/0048            | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer | 21/12/2022                          |                                             | Annex II and PL                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|           | for importation and/or batch release - including batch control/testing                                                                                                                                                                         |            |     | responsible Not   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-------------------|
| IAIN/0047 | B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes do not affect the properties of the FP | 06/12/2022 | n/a |                   |
| IAIN/0045 | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing         | 10/06/2022 | n/a |                   |
| IAIN/0044 | B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes do not affect the properties of the FP | 02/05/2022 | n/a |                   |
| IA/0043   | B.II.z - Quality change - Finished product - Other variation                                                                                                                                                                                   | 18/03/2022 | n/a |                   |
| IB/0042   | B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a Member State                          | 18/03/2022 | n/a |                   |
| IAIN/0041 | B.V.a.1.d - PMF - Inclusion of a new, updated or                                                                                                                                                                                               | 10/12/2021 | n/a |                   |

<div style=\"page-break-after: always\"></div>

|                     | amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes do not affect the properties of the FP                                                  |            |            |                                  |                                   |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-----------------------------------|
| PSUSA/10481 /202103 | Periodic Safety Update EU Single assessment - human coagulation factor X                                                                                                                                                                       | 30/09/2021 | n/a        |                                  | PRAC Recommendation - maintenance |
| IAIN/0040           | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                             | 07/07/2021 | n/a        |                                  |                                   |
| IAIN/0038           | B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes do not affect the properties of the FP | 24/03/2021 | n/a        |                                  |                                   |
| R/0031              | Renewal of the marketing authorisation.                                                                                                                                                                                                        | 28/01/2021 | 17/03/2021 | SmPC, Annex II, Labelling and PL |                                   |
| IAIN/0037           | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing         | 16/03/2021 | n/a        |                                  |                                   |
| IAIN/0036/G         | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                               | 13/01/2021 | 17/03/2021 | Annex II and PL                  |                                   |

<div style=\"page-break-after: always\"></div>

|                     | A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release                                                                                                                     |            |     |                                   |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| IAIN/0035           | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing         | 13/01/2021 | n/a |                                   |
| IB/0034             | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                     | 11/12/2020 | n/a |                                   |
| PSUSA/10481 /202003 | Periodic Safety Update EU Single assessment - human coagulation factor X                                                                                                                                                                       | 01/10/2020 | n/a | PRAC Recommendation - maintenance |
| IB/0029             | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                                                                     | 07/08/2020 | n/a |                                   |
| IB/0027             | B.II.z - Quality change - Finished product - Other variation                                                                                                                                                                                   | 21/07/2020 | n/a |                                   |
| IAIN/0032           | B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes do not affect the properties of the FP | 06/07/2020 | n/a |                                   |
| IAIN/0030           | B.V.a.1.d - PMF - Inclusion of a new, updated or                                                                                                                                                                                               | 11/06/2020 | n/a |                                   |

<div style=\"page-break-after: always\"></div>

|                     | amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes do not affect the properties of the FP                                                                          |            |            |                       |                                   |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------------|-----------------------------------|
| N/0024              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                       | 26/03/2020 | n/a        |                       |                                   |
| IAIN/0026           | B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes do not affect the properties of the FP                         | 13/03/2020 | n/a        |                       |                                   |
| IAIN/0025           | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                                 | 03/03/2020 | 17/03/2021 | SmPC, Annex II and PL |                                   |
| II/0023             | B.II.b.2.b - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place for a biol/immunol product and any of the test methods at the site is a biol/immunol method | 16/01/2020 | n/a        |                       |                                   |
| PSUSA/10481 /201903 | Periodic Safety Update EU Single assessment - human coagulation factor X                                                                                                                                                                                               | 03/10/2019 | n/a        |                       | PRAC Recommendation - maintenance |
| IAIN/0022/G         | This was an application for a group of variations.                                                                                                                                                                                                                     | 19/09/2019 | n/a        |                       |                                   |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes do not affect the properties of the FP B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes do not affect the properties of the FP B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes do not affect the properties of the FP B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes   |            |            |    |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----|
| N/0020    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 30/07/2019 | 17/03/2021 | PL |
| IAIN/0019 | B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes do not affect the properties of the FP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 19/07/2019 | n/a        |    |

<div style=\"page-break-after: always\"></div>

<!-- image -->

| IAIN/0021/G   | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 18/07/2019   | n/a   |
|---------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|
|               | B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes do not affect the properties of the FP B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes do not affect the properties of the FP B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes do not affect the properties of the FP B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes do not affect the properties of the FP B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes do not affect the properties of the FP B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes do not affect the properties of the FP |              |       |

<div style=\"page-break-after: always\"></div>

|                     | B.V.a.1.d - PMF - Inclusion of a new, updated or amended PMF in the marketing authorisation dossier of a medicinal product. (PMF 2nd step procedure) - Inclusion of an updated/amended PMF when changes do not affect the properties of the FP   |            |            |                        |                                   |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------|
| PSUSA/10481 /201809 | Periodic Safety Update EU Single assessment - human coagulation factor X                                                                                                                                                                         | 11/04/2019 | n/a        |                        | PRAC Recommendation - maintenance |
| T/0014              | Transfer of Marketing Authorisation                                                                                                                                                                                                              | 15/03/2019 | 28/03/2019 | SmPC, Labelling and PL |                                   |
| IAIN/0016           | B.IV.1.a.1 - Change of a measuring or administration device - Addition or replacement of a device which is not an integrated part of the primary packaging - Device with CE marking                                                              | 20/03/2019 | n/a        |                        |                                   |
| N/0012              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                 | 10/01/2019 | 28/03/2019 | Labelling              |                                   |
| IA/0010             | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                    | 26/10/2018 | n/a        |                        |                                   |
| PSUSA/10481 /201803 | Periodic Safety Update EU Single assessment - human coagulation factor X                                                                                                                                                                         | 04/10/2018 | n/a        |                        | PRAC Recommendation - maintenance |
| II/0009             | C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                                                                | 20/09/2018 | 28/03/2019 | SmPC and PL            |                                   |

<div style=\"page-break-after: always\"></div>

| II/0007             | Update of section sections 4.1, 4.2, 4.8, 5.1 and 5.2 of the SmPC in order to include safety and efficacy data in children aged less than 12 years of age based on final results from the study Ten02, a phase III open-label multicentre study to confirm the safety, pharmacokinetics and efficacy of BPL ' s high purity factor X in the prophylaxis of bleeding in factor X deficient children under the age of 12 years, provided in accordance with the agreed paediatric investigational plan. The Package Leaflet is updated accordingly. The RMP version 7.0 has also been submitted. C.I.6.a - Change(s) to therapeutic indication(s) - Addition of a new therapeutic indication or modification of an approved one   | 26/07/2018   | 27/08/2018   | SmPC and PL   | Please refer to the Scientific Discussion Coagadex EMEA/H/C/003855/II/0007.   |
|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|---------------|-------------------------------------------------------------------------------|
| IB/0006             | B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 23/05/2018   | n/a          |               |                                                                               |
| PSUSA/10481 /201709 | Periodic Safety Update EU Single assessment - human coagulation factor X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 12/04/2018   | n/a          |               | PRAC Recommendation - maintenance                                             |
| IB/0005             | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 14/12/2017   | n/a          |               |                                                                               |
| IB/0003             | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 14/11/2017   | n/a          |               |                                                                               |
| PSUSA/10481         | Periodic Safety Update EU Single assessment -                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 28/09/2017   | n/a          |               | PRAC Recommendation - maintenance                                             |

<div style=\"page-break-after: always\"></div>

| /201703     | human coagulation factor X                    |            |     |                                   |
|-------------|-----------------------------------------------|------------|-----|-----------------------------------|
| PSUSA/10481 | Periodic Safety Update EU Single assessment - | 06/04/2017 | n/a | PRAC Recommendation - maintenance |
| /201609     | human coagulation factor X                    |            |     |                                   |